Study of LM-302 in Patients With Advance Solid Tumors
NCT05161390
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
153
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumor
Interventions
DRUG:
LM-302 Injection
Sponsor
LaNova Medicines Zhejiang Co., Ltd.